We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
Cap. Flow
+$86.8M
Cap. Flow %
0.16%
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
2
ALC icon
Alcon
ALC
+$81.8M
3
NVDA icon
NVIDIA
NVDA
+$76M
4
GLW icon
Corning
GLW
+$50.4M
5
UNH icon
UnitedHealth
UNH
+$42.3M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$67.4M
2
FDS icon
Factset
FDS
+$62M
3
EEFT icon
Euronet Worldwide
EEFT
+$42.3M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$39.5M
5
OPLN
Openlane
OPLN
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Consumer Discretionary 17.74%
3 Financials 11.65%
4 Healthcare 11.2%
5 Communication Services 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNSL
726
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$0 ﹤0.01%
3
-1,502
-100% -$9.57K
PRFT
727
DELISTED
Perficient Inc
PRFT
-825
Closed -$23K
SWN
728
DELISTED
Southwestern Energy Company
SWN
-5,777
Closed -$27K
CMLS
729
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-10,474
Closed -$189K
DOOR
730
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-70,779
Closed -$3.53M
AEL
731
DELISTED
American Equity Investment Life Holding Company
AEL
-515
Closed -$14K
MDRX
732
DELISTED
Veradigm Inc. Common Stock
MDRX
-2,197
Closed -$21K
NVTA
733
DELISTED
Invitae Corporation
NVTA
-619,410
Closed -$14.5M
CHS
734
DELISTED
Chicos FAS, Inc.
CHS
-2,501
Closed -$11K
NXGN
735
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-1,491
Closed -$25K
NATI
736
DELISTED
National Instruments Corp
NATI
-292,710
Closed -$13M
SYNH
737
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-500
Closed -$26K
RTL
738
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-1,047
Closed -$11K
PDCE
739
DELISTED
PDC Energy, Inc.
PDCE
-390,728
Closed -$15.9M
BBBY
740
DELISTED
Bed Bath & Beyond Inc
BBBY
-1,556
Closed -$26K
VIVO
741
DELISTED
Meridian Bioscience Inc
VIVO
-1,041
Closed -$18K
BNFT
742
DELISTED
Benefitfocus, Inc.
BNFT
-400,754
Closed -$19.8M
FNHC
743
DELISTED
FedNat Holding Company Common Stock
FNHC
-13
Closed
EXTN
744
DELISTED
Exterran Corporation
EXTN
-603
Closed -$10K
CTXS
745
DELISTED
Citrix Systems Inc
CTXS
-242
Closed -$24K
MANT
746
DELISTED
Mantech International Corp
MANT
-367
Closed -$20K
MTOR
747
DELISTED
MERITOR, Inc.
MTOR
-1,198
Closed -$24K
TVTY
748
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-673
Closed -$12K
XENT
749
DELISTED
Intersect ENT, Inc
XENT
-396
Closed -$13K
DHR.PRA
750
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-82,960
Closed -$13.1M

Similar funds

Loomis, Sayles & Company's Q2 2019 Portfolio in Review

As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
  • Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
  • Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
  • Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
  • Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
  • Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.